Ensign Peak Advisors’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Ensign Peak Advisors's RVMD Position: Q3 2026 in Review
Ensign Peak Advisors increased its Revolution Medicines (RVMD) stake by 34% in Q3 2026, buying an estimated $1.67M and bringing the position to 33,483 shares worth $6.87M. The position accounts for 0.01% of the portfolio, ranked #511.
Ensign Peak Advisors first reported a position in RVMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $22.2M in Q1 2026. 745 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Ensign Peak Advisors held 33,483 shares of Revolution Medicines worth $6.87M as of Q3 2026.
- Ensign Peak Advisors bought 8,445 Revolution Medicines shares in Q3 2026, an estimated $1.67M.
- Revolution Medicines made up 0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #511 holding.
- Ensign Peak Advisors first reported a position in Revolution Medicines in Q3 2020 and has held it in 23 quarters since.
- Ensign Peak Advisors's Revolution Medicines position peaked at $22.2M in Q1 2026.
- 745 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.